Word

BASILEA

Status

Pending

Status Code

688

Status Date

Tuesday, April 9, 2024

Serial Number

97876573

Mark Type

3000

Filing Date

Thursday, April 6, 2023

Published for Opposition

Tuesday, February 13, 2024

Trademark Owner History

Basilea Pharmaceutica International AG,Allschwil - Owner At Publication

Classifications

5 Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of allergies; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical clinical purposes; clinical medical reagents; all of the aforesaid for prescription only

1 Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions and for the treatment of infections and diseases; chemical substances for use in research and development of pharmaceuticals for the treatment of dermatological conditions and for the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use

42 Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

The mark consists of the word "BASILEA" surrounded by an oval.
Color is not claimed as a feature of the mark.

Trademark Events

Apr 9, 2024

Noa E-Mailed - Sou Required From Applicant

Feb 13, 2024

Official Gazette Publication Confirmation E-Mailed

Feb 13, 2024

Published For Opposition

Jan 24, 2024

Notification Of Notice Of Publication E-Mailed

Jan 4, 2024

Approved For Pub - Principal Register

Jan 2, 2024

Assigned To Examiner

May 2, 2023

Notice Of Design Search Code E-Mailed

May 1, 2023

New Application Office Supplied Data Entered

Apr 10, 2023

New Application Entered